MARKET

HAE

HAE

Haemonetics Corp Mass
NYSE
57.01
+3.00
+5.55%
Pre Market: 55.00 -2.01 -3.53% 08:52 05/14 EDT
OPEN
53.26
PREV CLOSE
54.01
HIGH
57.47
LOW
53.17
VOLUME
166
TURNOVER
0
52 WEEK HIGH
87.32
52 WEEK LOW
47.32
MARKET CAP
2.65B
P/E (TTM)
15.66
1D
5D
1M
3M
1Y
5Y
1D
Haemonetics Is Maintained at Outperform by Barrington Research
Dow Jones · 1d ago
Haemonetics Price Target Cut to $89.00/Share From $94.00 by Barrington Research
Dow Jones · 1d ago
Barrington Research Maintains Outperform on Haemonetics, Lowers Price Target to $89
Benzinga · 1d ago
Haemonetics price target lowered to $89 from $94 at Barrington
TipRanks · 2d ago
Weekly Report: what happened at HAE last week (0504-0508)?
Weekly Report · 3d ago
Why Haemonetics (HAE) Is Down 9.5% After Mixed FY26 Results And FY27 Outlook Reset
Simply Wall St · 3d ago
A Look At Haemonetics (HAE) Valuation After Q4 Loss And Sector-Wide Medical Device Sell Off
Simply Wall St · 5d ago
Haemonetics Earnings Call Highlights Growth Amid Headwinds
TipRanks · 5d ago
More
About HAE
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.

Webull offers Haemonetics Corp stock information, including NYSE: HAE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HAE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HAE stock methods without spending real money on the virtual paper trading platform.